Reduced human neutrophil adhesion to porcine endothelia expressing human decay accelerating factor
Richards, A.C.; Tucker, A.W.; Carrington, C.A.; White, D.J.
Transplantation Proceedings 28(2): 636
1996
ISSN/ISBN: 0041-1345 PMID: 8623317 Document Number: 467477
Document emailed within 1 workday
Related Documents
Rosengard, A.M.; Cary, N.; Horsley, J.; Belcher, C.; Langford, G.; Cozzi, E.; Wallwork, J.; White, D.J. 1995: Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts Transplantation Proceedings 27(1): 326-327Post, T.W.; Arce, M.A.; Liszewski, M.K.; Thompson, E.S.; Atkinson, J.P.; Lublin, D.M. 1990: Structure of the gene for human complement protein decay accelerating factor Journal of Immunology 144(2): 740-744
Shibuya, K.; Abe, T.; Fujita, T. 1992: Decay-accelerating factor functions as a signal transducing molecule for human monocytes Journal of Immunology 149(5): 1758-1762
Shibata, T.; Cosio, F.G.; Birmingham, D.J. 1991: Complement activation induces the expression of decay-accelerating factor on human mesangial cells Journal of Immunology 147(11): 3901-3908
Coyne, K.E.; Hall, S.E.; Thompson, S.; Arce, M.A.; Kinoshita, T.; Fujita, T.; Anstee, D.J.; Rosse, W.; Lublin, D.M. 1992: Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor Journal of Immunology 149(9): 2906-2913
Cary, N.; Moody, J.; Yannoutsos, N.; Wallwork, J.; White, D. 1993: Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection Transplantation Proceedings 25(1 Pt 1): 400-401
Ramirez, P.; Chavez, R.; Majado, M.; Munitiz, V.; Muñoz, A.; Hernandez, Q.; Palenciano, C.G.; Pino-Chavez, G.; Loba, M.; Minguela, A.; Yelamos, J.; Gago, M.R.; Vizcaino, A.S.; Asensi, H.; Cayuela, M.G.; Segura, B.; Marin, F.; Rubio, A.; Fuente, T.; Robles, R.; Bueno, F.S.; Sansano, T.; Acosta, F.; Rodriguez, J.M.; Navarro, F.; Cabezuelo, J.; Cozzi, E.; White, D.J.; Calne, R.Y.; Parrilla, P. 2000: Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days Transplantation 70(7): 989-998
Pearce, E.J.; Hall, B.F.; Sher, A. 1990: Host-specific evasion of the alternative complement pathway by schistosomes correlates with the presence of a phospholipase C-sensitive surface molecule resembling human decay accelerating factor Journal of Immunology 144(7): 2751-2756
Iwata, K.; Seya, T.; Ariga, H.; Nagasawa, S. 1994: Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein Journal of Immunology 152(7): 3436-3444
Pöhlein, C.; Pascher, A.; Storck, M.; Young, V.K.; König, W.; Abendroth, D.; Wick, M.; Thiery, J.; White, D.J.; Hammer, C. 1996: Transgenic human DAF-expressing porcine livers: their function during hemoperfusion with human blood Transplantation Proceedings 28(2): 770-771
Broudy, V.C.; Harlan, J.M.; Adamson, J.W. 1987: Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells Journal of Immunology 138(12): 4298-4302
Nicholson-Weller, A.; Burge, J.; Fearon, D.T.; Weller, P.F.; Austen, K.F. 1982: Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system Journal of Immunology 129(1): 184-189
Choi-Miura, N.H. 1999: Decay-accelerating factor (DAF; CD55) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 79-81
Quigg, R.J.; Nicholson-Weller, A.; Cybulsky, A.V.; Badalamenti, J.; Salant, D.J. 1989: Decay accelerating factor regulates complement activation on glomerular epithelial cells Journal of Immunology 142(3): 877-882
Kammer, G.M.; Walter, E.I.; Medof, M.E. 1988: Association of cytoskeletal re-organization with capping of the complement decay-accelerating factor on T lymphocytes Journal of Immunology 141(9): 2924-2928
Brodbeck, W.G.; Liu, D.; Sperry, J.; Mold, C.; Medof, M.E. 1996: Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor Journal of Immunology 156(7): 2528-2533
Birmelé, B.; Thibault, G.; Watier, H.; Vallée, I.; Gruel, Y.; Nivet, H.; Salmon, H.; Bardos, P.; Lebranchu, Y. 1994: Human peripheral blood lymphocyte adhesion to xenogeneic porcine aortic endothelial cells: preferential adhesion of CD3-CD16+ NK cells Transplantation Proceedings 26(3): 1150-1151
Higgins, P.J.; Ko, J.L.; Lobell, R.; Sardonini, C.; Alessi, M.K.; Yeh, C.G. 1997: A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities Journal of Immunology 158(6): 2872-2881
Shi, Z.; Fan, L.; Qiang, H.; Tang, Y.; Wang, K.; Dang, X. 2010: Study on biological activity of recombinant adeno-associated virus vector co-expressing human vascular endothelial growth factor 165 and human bone morphogenetic protein 7 genes in vitro Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24(4): 415-419
Ward, T.; Pipkin, P.A.; Clarkson, N.A.; Stone, D.M.; Minor, P.D.; Almond, J.W. 1994: Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method EMBO Journal 13(21): 5070-5074